42 studies found for:    obstetrics | NICHD
Show Display Options
Rank Status Study
21 Completed Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission
Condition: HIV Infections
Interventions: Procedure: Intrapartum HIV counseling/testing;   Procedure: Postpartum HIV counseling/testing
22 Recruiting Prenatal Microarray Follow-Up Study
Condition: Genetic Diseases
Intervention: Other: 3-year follow-up
23 Active, not recruiting Combined Treatment for Mixed Incontinence
Conditions: Urinary Incontinence, Stress;   Urinary Incontinence, Urge
Interventions: Procedure: Miduretheral Sling;   Other: Miduretheral Sling with behavioral/pelvic floor therapy
24 Completed Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
Condition: HIV Infections
Interventions: Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate
25 Completed Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Conditions: HIV Infections;   Pregnancy Complications, Infectious
Intervention: Behavioral: Adherence assessment
26 Completed Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery
Condition: HIV Infections
Intervention: Drug: Tenofovir 1% vaginal gel
27 Recruiting Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant Women
Condition: Cigarette Smoking
Interventions: Behavioral: Best practices;   Behavioral: financial incentives
28 Completed Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)
Condition: HIV
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)
29 Completed Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV vCP1521;   Biological: ALVAC HIV-1 vCP1521
30 Completed Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)
Condition: Urinary Incontinence, Urge
Interventions: Device: InterStim® device;   Drug: Botox® injection
31 Completed Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
Condition: HIV Infections
Interventions: Drug: Lamivudine, nevirapine, and stavudine fixed-dose tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Stavudine
32 Completed Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand
Condition: HIV Infections
Interventions: Drug: GPO-Vir Z30 tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Zidovudine
33 Completed Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Conditions: Pregnancy;   Pregnancy Complications
Intervention:
34 Completed
Has Results
PREGNANT Short Cervix Trial
Conditions: Preterm Delivery;   Short Cervix;   Short Uterine Cervical Length
Interventions: Drug: progesterone;   Drug: placebo
35 Completed Effects of a Kappa Agonist on Hot Flashes in Menopausal Women
Condition: Treatment of Menopausal Hot Flashes
Interventions: Drug: Standard Dose Kappa Agonist;   Drug: Half Dose Kappa Agonist;   Other: Placebo
36 Completed Safety and Acceptability of a Vaginal Microbicide
Conditions: HIV Infections;   Hepatitis B, Chronic
Intervention: Drug: 1% tenofovir gel
37 Completed
Has Results
Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth
Condition: HIV Infections
Interventions: Drug: Didanosine, enteric-coated;   Drug: Lopinavir/ritonavir;   Drug: Nevirapine;   Drug: Zidovudine
38 Recruiting Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Condition: HIV Infections
Interventions: Drug: atazanavir/cobicistat;   Drug: darunavir/ritonavir;   Drug: darunavir/cobicistat;   Drug: etravirine;   Drug: elvitegravir/cobicistat;   Drug: dolutegravir;   Drug: tenofovir alafenamide fumarate (TAF);   Drug: TAF/cobicistat;   Drug: TAF/ritonavir;   Drug: efavirenz;   Drug: lopinavir/ritonavir;   Drug: nevirapine;   Drug: rifampicin;   Drug: ethambutol;   Drug: isoniazid;   Drug: pyrazinamide;   Drug: kanamycin;   Drug: amikacin;   Drug: capreomycin;   Drug: moxifloxacin;   Drug: levofloxacin;   Drug: ofloxacin;   Drug: ethionamide/prothionamide;   Drug: terizidone/cycloserine;   Drug: para-aminosalicylic acid (PAS);   Drug: high dose isoniazid (INH);   Drug: bedaquiline;   Drug: clofazamine;   Drug: delamanid;   Drug: linezolid;   Drug: pretomanid;   Drug: atazanavir/ritonavir/tenofovir;   Drug: ethinyl estradiol oral contraceptive;   Drug: etonogestrel implant
39 Unknown  Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol
Condition: Contraception
Intervention: Drug: NES/EE CVR
40 Completed
Has Results
Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Nevirapine placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.